Molecular Genetics and Metabolism · 2024 · 12 citations · 31 references
MedicineEndocrinologyPediatricsBone MetabolismHuman NutritionPediatric EndocrinologyAmino Acid Metabolism DisordersBone Metabolism DisordersNeonatal Metabolic DisordersProtein RequirementsUrea CycleUrea Cycle DisordersBone Mineral DensityBone Mineral Density DeclineInborn Errors Of Urea Cycle MetabolismMaple Syrup Urine DiseaseNutritional Determinants Of GrowthProtein-restricted DietsPubertal ChangesPubertal Delay
OBJECTIVES: Inherited amino-acid metabolism disorders (IAAMDs) require lifelong protein-restricted diet. We aimed to investigate: 1/ whether IAAMDs was associated with growth, pubertal, bone mineral apparent density (BMAD) or body composition impairments; 2/ associations linking height, amino-acid mixture (AAM), plasma amino-acids and IGF1 concentrations. DESIGN: Retrospective longitudinal study of 213 patients with neonatal-onset urea cycle disorders (UCD,n = 77), organic aciduria (OA,n = 89), maple syrup urine disease (MSUD,n = 34), or tyrosinaemia type 1 (n = 13). METHODS: We collected growth parameters, pubertal status, BMAD, body composition, protein-intake, and IGF1 throughout growth. RESULTS: Overall final height (n = 69) was below target height (TH): -0.9(1.4) vs. -0.1(0.9) SD, p < 0.001. Final height was ≤ TH-2SD in 12 (21%) patients. Height ≤ - 2SD was more frequent during puberty than during early-infancy and pre-puberty: 23.5% vs. 6.9%, p = 0.002; and vs. 10.7%, p < 0.001. Pubertal delay was frequent (26.7%). Height (SD) was positively associated with isoleucine concentration: β, 0.008; 95%CI, 0.003 to 0.012; p = 0.001. In the pubertal subgroup, height (SD) was lower in patients with vs. without AAM supplementation: -1.22 (1.40) vs. -0.63 (1.46) (p = 0.02). In OA, height and median (IQR) isoleucine and valine concentrations(μmol/L) during puberty were lower in patients with vs. without AAM supplementation: -1.75 (1.30) vs. -0.33 (1.55) SD, p < 0.001; and 40 (23) vs. 60 (25) (p = 0.02) and 138 (92) vs. 191 (63) (p = 0.01), respectively. No correlation was found with IGF1. Lean-mass index was lower than fat-mass index: -2.03 (1.15) vs. -0.44 (0.89), p < 0.001. CONCLUSIONS: In IAAMDs, growth retardation worsened during puberty which was delayed in all disease subgroups. Height seems linked to the disease, AAM composition and lower isoleucine concentration, independently of the GH-IGF1 pathway. We recommend close monitoring of diet during puberty.
31
Updated Data on Proximal Femur Bone Mineral Levels of US Adults
Anne C. Looker, Heinz W. Wahner, W. L. Dunn et al. · Osteoporosis International · 1998 · 1.1K citations
Martin Bidlingmaier, Nele Friedrich, Rebecca T. Emeny et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 388 citations · Full text
Medicine, Endocrinology, Aging +15
Child Stunting is Associated with Low Circulating Essential Amino Acids
Richard D. Semba, Michelle Shardell, Fayrouz A Sakr Ashour et al. · EBioMedicine · 2016 · 343 citations · Full text